Table 1.

Hypertension Thresholds, Goals, and Agents in Diabetics

Guideline	Year Published	Threshold for Treatment	Goal Blood Pressure	First‐Line Agents
JNC 74	2004	≥130/80	≤130/80	ACE inhibitor, ARB, BB, CCB
JNC 85	2014	≥140/90	≤140/90	Nonblacks: thiazide‐type diuretic, ACE inhibitor, ARB, or CCB Blacks: thiazide‐type diuretic or CCB
ASH/ISH8	2014	≥140/90	≤140/90	Diabetics: ACE inhibitor or ARB Blacks: thiazide‐type diuretic or CCB
ESH/ESC6	2013	≥140/85	≤140/85	ACE inhibitor or ARB
CHEP10	2014	≥130/80	≤130/80	ACE inhibitor, ARB, CCB, thiazide‐type diuretic
ADA7	2013	≥140/80	≤140/80	ACE inhibitor or ARB
WHO/ISH9	2003	≥130/80	≤130/80	ACE inhibitor or ARB

Abbreviations: ACE, angiotensin‐converting inhibitor; ADA, American Diabetes Association; ARB, angiotensin receptor blocker; ASH, American Society of Hypertension; BB, β‐blocker; CCB, calcium channel blocker; CHEP, Canadian Hypertension Education Program; ESH/ESC, European Society of Hypertension/European Society of Cardiology; ISH, International Society of Hypertension; JNC 7, Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; JNC 8, Eighth Report of the Joint National Committee; WHO, World Health Organization.